Initial clinical experience with the HeartWare left ventricular assist system: a single-center report.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Annals of Thoracic Surgery

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.athoracsur.2012.08.052PMID 23141906
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Initial clinical experience with the HeartWare left ventricular assist system: a single-center report.

  2013cited by this paper
• Model for end-stage liver disease score predicts adverse events related to ventricular assist device therapy.

  2012cited by this paper
• The Fourth INTERMACS Annual Report: 4,000 implants and counting.

  2012cited by this paper
• Advances in mechanical circulatory support: year in review.

  2011cited by this paper
• Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices.

  2011cited by this paper
• Biventricular Circulatory Support With Two Miniaturized Implantable Assist Devices

  2011cited by this paper
• Extracorporeal membrane oxygenation as perioperative right ventricular support in patients with biventricular failure undergoing left ventricular assist device implantation.

  2011cited by this paper
• Arteriovenous malformation and gastrointestinal bleeding in patients with the HeartMate II left ventricular assist device.

  2011cited by this paper
• Multicenter evaluation of an intrapericardial left ventricular assist system.

  2011cited by this paper
• Relative roles of heart transplantation and long-term mechanical circulatory support in contemporary management of advanced heart failure - a critical appraisal 10 years after REMATCH.

  2011cited by this paper
• Early adverse events as predictors of 1-year mortality during mechanical circulatory support.

  2010cited by this paper
• Model for End-Stage Liver Disease Score Predicts Left Ventricular Assist Device Operative Transfusion Requirements, Morbidity, and Mortality

  2010influential reference
• Clinical management of continuous-flow left ventricular assist devices in advanced heart failure.

  2010influential reference
• Hematologic Effects of Continuous Flow Left Ventricular Assist Devices

  2010cited by this paper
• Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial.

  2010cited by this paper
• Second INTERMACS annual report: more than 1,000 primary left ventricular assist device implants.

  2010cited by this paper
• NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial.

  2010cited by this paper
• European results with a continuous-flow ventricular assist device for advanced heart-failure patients.

  2009cited by this paper
• Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device.

  2009cited by this paper
• Magnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparison.

  2007cited by this paper
• First clinical experience with the Incor left ventricular assist device.

  2005cited by this paper
• Long-term use of a left ventricular assist device for end-stage heart failure.

  2001cited by this paper
• Beating Heart Implantation of a Wearable NOVACOR Left-Ventricular Assist Device

  1996cited by this paper
• Clinical use of the total artificial heart.

  1984cited by this paper
• Left ventricular bypass pump for cardiac assistance. Clinical experience.

  1971cited by this paper

• Does infection predispose to thrombosis during long term ventricular assist device support?

  2022cites this paper
• Contemporary outcomes of continuous-flow left ventricular assist devices-a systematic review.

  2021cites this paper
• Neutrophil to Lymphocyte Ratio Is Related to Thrombotic Complications and Survival in Continuous Flow Left Ventricular Assist Devices

  2020cites this paper
• Association between the low percentage of forced vital capacity and increased mortality after left ventricular assist device implantation

  2020cites this paper
• Initial conservative management strategy of HeartWare left ventricular assist device thrombosis with intravenous heparin or bivalirudin

  2019cites this paper
• In Vitro Benchmarking Study of Ventricular Assist Devices in Current Clinical Use.

  2019cites this paper
• Current management and perspectives in the treatment of ventricular assist device-specific infections.

  2019cites this paper
• Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography for improving diagnosis of infection in patients on CF-LVAD: longing for more ‘insights’

  2018cites this paper
• Long‐term evaluation of a fully magnetically levitated circulatory support device for advanced heart failure—two‐year results from the HeartMate 3 CE Mark Study

  2018cites this paper
• Implantable Left Ventricular Assist Device Therapy-Recent Advances and Outcomes.

  2017cites this paper
• Clinical Outcomes Following Continuous-Flow Left Ventricular Assist Device:

  2017cites this paper
• Heartmate 3 fully magnetically levitated left ventricular assist device for the treatment of advanced heart failure –1 year results from the Ce mark trial

  2017cites this paper
• Metabolic volume performs better than SUVmax in the detection of left ventricular assist device driveline infection

  2017cites this paper
• HeartWare-HVAD for end-stage heart failure: a review of clinical experiences with ≥50 patients

  2017cites this paper
• Impact of aortic valve closure on adverse events and outcomes with the HeartWare ventricular assist device.

  2017cites this paper
• Contributory Role of Fluorine 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Diagnosis and Clinical Management of Infections in Patients Supported With a Continuous-Flow Left Ventricular Assist Device.

  2016cites this paper
• Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.

  2015cites this paper
• Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study.

  2015cites this paper
• Characterization of real time platelet deposition onto opaque surfaces under clinically-relevant flow conditions

  2015influential citation
• How to cope with a temporarily aborted transplant program: solutions for a prolonged waiting period.

  2015cites this paper
• Neurologic aspects of cardiac emergencies.

  2014cites this paper
• Outcomes in patients receiving HeartMate II versus HVAD left ventricular assist device as a bridge to transplantation.

  2014cites this paper
• Initial experience in Japan with HeartWare ventricular assist system

  2014cites this paper
• ICD Lead Parameters, Performance, and Adverse Events following Continuous‐Flow LVAD Implantation

  2014cites this paper
• Outcomes and Predictors of Early Mortality After Continuous-Flow Left Ventricular Assist Device Implantation as a Bridge to Transplantation

  2014cites this paper
• QRS complex fragmentation and survival following left ventricular assist device implantation

  2014cites this paper
• A retrospective evaluation of fondaparinux for confirmed or suspected heparin-induced thrombocytopenia in left-ventricular-assist device patients

  2014cites this paper
• Multicentre Canadian experience with the HeartWare ventricular assist device: concerns about adverse neurological outcomes.

  2014cites this paper
• Biventricular assist device implantation as bridge to transplantation after Mustard procedure.

  2014cites this paper
• Initial experience in Japan with HeartWare ventricular assist

  2014cites this paper
• Hjertepumper (LVAD) som varig behandling av pasienter med alvorlig hjertesvikt

  2013cites this paper
• Hypoxemia in a patient with biventricular HeartWare® ventricular assist devices

  2013cites this paper
• HeartWare miniaturized intrapericardial ventricular assist device: advantages and adverse events in comparison to contemporary devices

  2013cites this paper
• Implantation of the continuous flow HeartWare® left ventricular assist device.

  2013cites this paper
• Initial clinical experience with the HeartWare left ventricular assist system: a single-center report.

  2013cites this paper
• Invited commentary.

  2013cites this paper